Kyoto
Japan
Kyoto Prefectural University of Medicine - Department of Biostatistics
Non-small cell lung cancer, nab-paclitaxel, Low dose, Phase 2
nab-paclitaxel, optimal dose, advanced NSCLC
STAS, prediction, preoperative biopsy, Lung adenocarcinoma, histological pattern